“Formulation Strategies and In Vitro Characterization of Talquetamab-Loaded Nanocarriers for Targeted Immunotherapy in Multiple Myeloma” (2026) International Journal of Research Development and Technology, 4(1), pp. 41–61. doi:10.62218/ijrdt.v4i1.166.